Product Information
INVOKAMET XR 150-500 MG TABLET is a brand product labeled by Janssen Pharmaceuticals Inc., priced at $9.5612 per EA under NDC 50458094201. Its NADAC has been published 353 times since Aug 23, 2017.
FDA first approved this application on Sep 20, 2016.
Strength
150; 500 mg/1; mg/1
Manufacturer
Janssen Pharmaceuticals Inc.NDC
50458094201
Classification
Brand
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA205879FDA Approved
9/20/2016
On Market Since
9/20/2016
Pharmacological Classes
Price Statistics
The NADAC for INVOKAMET XR 150-500 MG TABLET has been published 353 times since Aug 23, 2017, and over the history we have for it it has risen 39.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.5612 per EA |
|---|---|
| All-time high | $9.6176 (Apr 16, 2025) |
| All-time low | $6.8402 (Aug 23, 2017) |
| 52-week high | $9.5958 |
| 52-week low | $9.5373 |
| Median price | $8.3252 |
| Average price | $8.5345 |
| Largest weekly change | +10.4% (Apr 17, 2024) |
| Weeks tracked | 353 |
| Tracking since | Aug 23, 2017 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of INVOKAMET XR 150-500 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for INVOKAMET XR 150-500 MG TABLET, manufactured by Janssen Pharmaceuticals Inc., is $9.5612 per EA (NDC 50458094201), effective Aug 19, 2026.
How has the price of INVOKAMET XR 150-500 MG TABLET changed over time?
Over the history we have for it, the NADAC for INVOKAMET XR 150-500 MG TABLET has risen 39.8%. It has been tracked across 353 weekly CMS publications since Aug 23, 2017.
What are the highest and lowest recorded NADAC prices for INVOKAMET XR 150-500 MG TABLET?
Since Aug 23, 2017, the NADAC for INVOKAMET XR 150-500 MG TABLET has ranged from a low of $6.8402 (Aug 23, 2017) to a high of $9.6176 (Apr 16, 2025), with a median of $8.3252 per EA.
Are there cheaper alternatives to INVOKAMET XR 150-500 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as INVOKAMET XR 150-500 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures INVOKAMET XR 150-500 MG TABLET?
INVOKAMET XR 150-500 MG TABLET (NDC 50458094201) is labeled by Janssen Pharmaceuticals Inc., and CMS classifies it as a brand product.